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INTRODUCTION:  Perianal  extra-mammary  Paget’s  disease  is  a rare  skin  disorder  of  unknown  aetiology,
which  is  frequently  associated  with  malignancy.  This  case  report  draws  attention  to  this rare  condition
and  comments  upon  its diagnosis  and  treatment.
PRESENTATION OF  CASE:  A 64-year-old  otherwise  ﬁt  man,  presented  to  us in  2006  with  one-year-long
history  of perianal  irritation.  On examination  there  was  an  erythematous  discoid  skin  lesion  in the right
perianal  area.  The  lesion  was  excised  with  wide  margins  and  the  defect  closed  with  a  local  transposition
ﬂap.  Histology  conﬁrmed  extra-mammary  Paget’s  disease  (EMPD)  with  a focus  of invasion  showing  a
well-differentiated  mucinous  adenocarcinoma.  Adjuvant  therapy  was  not  advised.  On  follow-up  in  2011,
a  small  irregular  skin  lesion,  well  away  from  the  previous  excision  site was  noted  on  the  left  perianal
area.  Biopsies  from  this  lesion  conﬁrmed  EMPD  with  no focus  of  invasion.  Once  again  wide local  excision
with  closure  using  local  transposition  ﬂap  was  undertaken.  Long  term  follow  up  has  been  advised.
DISCUSSION: The  optimal  treatment  for  Perianal  Paget’s  disease  (PPD)  remains  controversial.  Surgery
is  the  commonest  modality  used  with  wide  local  excision  being  the  treatment  of choice  for  resectable
disease.  We  report  herein  a short  review  of various  therapies  reported  so  far  in  the  management  of this
rare  disorder.
CONCLUSION:  A thorough  initial  evaluation  and  long-term  follow-up  is  essential  to  identify  recurrence
and  the  development  of  other  related  malignancies.
gical .© 2012 Sur
. Introduction
Extramammary Paget’s disease (EMPD) is a rare skin disorder
nvolving adult Caucasians. The disease usually involves skin areas
ich in apocrine glands such as axilla and anogenital region. Vulva
s by far the commonest anogenital site with perianal involvement
eing a distinct rarity. We  report herein a recent case of Perianal
aget’s disease (PPD) managed successfully at our unit.
.  Case report
A  64-year-old otherwise ﬁt man, presented to us in 2006 with
ne-year-long history of perianal irritation and minimal rectal
leeding. He did not report any weight loss or other alarm gas-
rointestinal symptoms. His past medical history included banding
or haemorrhoids and complete excision of a severely dysplastic
ectal polyp in 2000. Surveillance colonoscopy in 2004 was normal
nd the patient was discharged. Local examination revealed an ery-
hematous discoid skin lesion in the right perianal area measuring
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2 cm × 2 cm with surrounding licheniﬁcation. Rectal examination
was normal apart from small internal haemorrhoids. Abdomi-
nal examination was unremarkable and inguinal glands were not
palpable. The perianal skin biopsy was consistent with EMPD. Sub-
sequent colonoscopy and CT scan of the chest, abdomen and pelvis
were negative. The lesion was  excised with wide margins and the
defect was closed using a local transposition ﬂap. Histology con-
ﬁrmed EMPD with a focus of invasion showing a well-differentiated
mucinous adenocarcinoma. Findings were discussed at the anal
MDT meeting and a close follow-up with no adjuvant therapy was
advised.
Follow-up visit in 2011 revealed healthy right perianal area
with no evidence of recurrence. However a small irregular skin
lesion was noted on the left perianal area. Biopsies from this lesion
conﬁrmed EMPD with no focus of invasion. Further workup includ-
ing scans, endoscopy and tumour markers were unrewarding. He
underwent an uneventful wide local excision of the left perianal
area with reconstruction using a transposition ﬂap. A close follow-
up has been advised.
3.  Discussion
Open access under CC BY-NC-ND licensePerianal Paget’s disease (PPD) is a rare intraepithelial adeno-
carcinoma of unknown aetiology, characterised histologically by
the presence of malignant Paget cells in the epidermis. PPD repre-
sents 20% of cases of extra-mammary Paget’s disease and 6.5% of all
  BY-NC-ND license.
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Fig. 1. 5X HE image of extramammary Paget’s disease with focus of stromal invasion.
Recent literature demonstrates the therapeutic advantage of
photodynamic therapy (PDT) in preserving the anus and its func-
tion when managing PPD. The size and margins of tumour canCASE  REPORT
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ases of Paget’s disease.1 Recent work has supported the view that
aget cells in extramammary Paget’s disease (EMPD) are glandu-
ar cells of apocrine origin as indicated by the expression of gross
ystic disease ﬂuid protein (GCDFP) antigen, low molecular weight
ytokeratins and carcinoembryonic antigen.1
The ﬁrst report on EMPD was by Darier and Coulillaud in 1893,2
lmost two decades after Sir James Paget ﬁrst described the char-
cteristic mammary lesion. There has been much controversy as to
hether Paget’s disease is a primary disorder or a manifestation of
n underlying subjacent or distant invasive carcinoma. Helwig and
raham studied 40 patients with anogenital Paget’s disease, seven
f whom had extra-cutaneous malignancy. Four of these had rectal
denocarcinoma.3 A case of PPD complicated by Grade 2 squamous
arcinoma was reported by Nelson.4
PPD disease should be considered in middle-aged or elderly
atients who present with a long history of pruritus ani refractory
o local medical treatment. The typical ﬁnding on examination is an
rythematous, well-circumscribed plaque that may  be ulcerative,
rusty or papillary. Full thickness biopsies of the affected perianal
kin with mapping biopsies must be obtained for precise preoper-
tive histological assessment.5 Subsequent workup such as scans
nd endoscopy to exclude any underlying primary malignancy is
rucial for accurate diagnosis, prognosis and treatment.
The depth of invasion, lymph node involvement and metastatic
pread of the disease deﬁne the management of PPD. The treat-
ent of choice is wide local excision with at least 1 cm clearance.2
esultant defects generally require local or regional ﬂaps to bridge
he gap and secure a better functional outcome. Aggressive sur-
ical approach with radical excision results in signiﬁcant tissue
oss and poses a cosmetic and functional challenge to surgeons.
am et al.6 described staged excision and split-thickness skin graft
or the management of circumferential perianal lesions. Favourable
utcomes have been reported with the use of transposition or rota-
ion skin ﬂaps, bilateral myocutaneous ﬂaps of the gluteal and
high muscles and V-Y island ﬂaps to cover the areas of tissue
oss.7 Mohs micrographic surgery (MMS)  has been reported to be
n effective and superior technique compared to standard surgi-
al management for circumferential PPD.8 The technique allows
or maximal tissue sparing of critical anatomical structures and is
erformed under local anaesthesia as an outpatient. Nevertheless,
ocal recurrence rates for both conventional excision and MMS  are
ell documented in the literature with quoted ﬁgures of 23% and
1–61% respectively (Figs. 1–3).9,10
Despite their contentious role, the use of non-surgical modal-
ties constitutes a reasonable alternative to surgery. Indications
nclude elderly and high-risk patients, inoperable tumours, unwill-
ngness for mutilating surgery and those with occult and multifocal
isease. Radiotherapy may  be employed as an adjunct to surgery
to reduce long term local recurrence) or to treat post-operative
ocal recurrence.9 Use of radiotherapy as a primary therapeu-
ic modality is also well established. Yanagi et al. reported their
xperience of genital EMPD managed successfully by radiother-
py (40–50 Gy) in elderly patients.11 For patients with EMPD and
denocarcinoma, doses of >55 Gy or concurrent chemotherapy may
e indicated. High dose radiotherapy to the perianal area is often
ssociated with enteritis, proctitis and cystitis and may  result in
olostomy.9
EMPD has also been managed with topical chemotherapeu-
ic agent such as 5-ﬂuorouracil (5FU), bleomycin and imiquimod.
ocal 5-ﬂuorouracil has been employed for symptomatic relief
nd cytoreduction before operative management.12 Watring et al.
chieved 57% complete remission with topical bleomycin in
atients with recurrent non-invasive vulval EMPD.13 Case reports
ave recorded complete response to systemic mitomycin C and
-FU.14 In cases where surgery and radiotherapy are contraindi-
ated, chemotherapy can be the chosen mode of treatment. OverFig. 2. Recurrence of Perianal Paget’s disease on the left.
expression of HER-2 protein is seen in 20–60% cases of EMPD
and signiﬁes poor prognosis often due to deep dermal invasion or
metastatic disease. Combination systemic therapy with paclitaxel
and transtuzumab has been used in metastatic EMPD with HER-2
over-expression with high response rates.15Fig. 3. Wide local excision of the left perianal area and reconstruction with a trans-
position  ﬂap.
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e identiﬁed by ALA/PpIX-mediated ﬂuorescence examination
5 aminolevulinic acid/protoporphyrin IX) thus ascertaining PDT
reatment of the entire tumour lesion.16 Advantages of PDT include:
ow toxicity, better cancer selectivity and ability to be repeated.
ntralesional interferon (IFN alfa-2b) has been used successfully in
eo-adjuvant setting to downgrade PPD enabling a less mutilating
esection with long term remission.17
. Conclusion
PPD is a rare disorder, which continues to pose a diagnostic and
herapeutic challenge. Wide local excision remains the treatment of
hoice with an evolving role for various adjuvant therapies. Despite
dequate resection long term out look remains guarded due to high
ecurrence rate.
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